Literature DB >> 30111584

Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Atrial Fibrillation.

Wolfgang C Winkelmayer1.   

Abstract

Entities:  

Keywords:  Atrial Fibrillation; Cardiovascular Diseases; Cardiovascular System; Kidney Diseases; Risk Reduction Behavior; cardiovascular; risk factors

Year:  2018        PMID： 30111584      PMCID： PMC6140555          DOI： 10.2215/CJN.06270518

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Authors:  Konstantinos C Siontis; Xiaosong Zhang; Ashley Eckard; Nicole Bhave; Douglas E Schaubel; Kevin He; Anca Tilea; Austin G Stack; Rajesh Balkrishnan; Xiaoxi Yao; Peter A Noseworthy; Nilay D Shah; Rajiv Saran; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

Review 2.  Vitamin K antagonists: beyond bleeding.

Authors:  Thilo Krüger; Jürgen Floege
Journal:  Semin Dial       Date:  2014 Jan-Feb       Impact factor: 3.455

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.

Authors:  Ziad Hijazi; Lars Wallentin
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

5.  Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Faye L Lopez; Kunihiro Matsushita; Laura R Loehr; Sunil K Agarwal; Lin Y Chen; Elsayed Z Soliman; Brad C Astor; Josef Coresh
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

6.  Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Authors:  Kevin E Chan; Elazer R Edelman; Julia B Wenger; Ravi I Thadhani; Franklin W Maddux
Journal:  Circulation       Date:  2015-01-16       Impact factor: 29.690

7.  Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.

Authors:  Prabir Roy-Chaudhury; Jim A Tumlin; Bruce A Koplan; Alexandru I Costea; Vijay Kher; Don Williamson; Saurabh Pokhariyal; David M Charytan
Journal:  Kidney Int       Date:  2018-02-12       Impact factor: 10.612

Review 8.  Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

Authors:  Kevin E Chan; Robert P Giugliano; Manesh R Patel; Stuart Abramson; Meg Jardine; Sophia Zhao; Vlado Perkovic; Franklin W Maddux; Jonathan P Piccini
Journal:  J Am Coll Cardiol       Date:  2016-06-21       Impact factor: 24.094

9.  Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).

Authors:  Oliver Königsbrügge; Florian Posch; Marlies Antlanger; Josef Kovarik; Renate Klauser-Braun; Josef Kletzmayr; Sabine Schmaldienst; Martin Auinger; Günther Zuntner; Matthias Lorenz; Ella Grilz; Gerald Stampfel; Stefan Steiner; Ingrid Pabinger; Marcus Säemann; Cihan Ay
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

10.  Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Mintu P Turakhia; Peter J Blankestijn; Juan-Jesus Carrero; Catherine M Clase; Rajat Deo; Charles A Herzog; Scott E Kasner; Rod S Passman; Roberto Pecoits-Filho; Holger Reinecke; Gautam R Shroff; Wojciech Zareba; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christoph Wanner
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983
View more
  1 in total

1.  The ABCs in the Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: An Introductory Remark on Expert Perspectives.

Authors:  Christoph Wanner
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-15       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.